Crizotinib

• Description :

  Crizotinib (PF-02341066; PF-2341066) is a potent, selective, orally bioavailable, ATP-competitive inhibitor of c-Met catalytic activity with Ki of 4 nM.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  450.3367

• Molecular Formula :

  C21H22Cl2FN5O

• Notes :

  Research use only, not for human use.

• Receptor :

  ALK|c-Met

• CAS Number :

  877399-52-5